Is bipolar disorder an inflammatory condition? The relevance of microglial activation

Elevation of cerebrospinal fluid interleukin-1β in bipolar disorder

(2014) Johan Söderlund et al.   JOURNAL OF PSYCHIATRY & NEUROSCIENCE

Neuroprogression in bipolar disorder

(2012) Marguerite Reid Schneider et al.   BIPOLAR DISORDERS

Minocycline

(2012) Olivia M. Dean et al.   CNS DRUGS

Lithium pretreatment reduces brain injury after intracerebral hemorrhage in rats

(2012) K Kang et al.   NEUROLOGICAL RESEARCH

Valproic acid ameliorates inflammation in experimental autoimmune encephalomyelitis rats

(2012) Z. Zhang et al.   NEUROSCIENCE

Microglia in the developing brain: A potential target with lifetime effects

(2012) G. Jean Harry et al.   NEUROTOXICOLOGY

Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2×2 clinical trial

(2012) Jonathan Savitz et al.   BMJ Open

Microglial Activation – Tuning and Pruning Adult Neurogenesis

(2012) Christine T. Ekdahl   Frontiers in Pharmacology

Illness burden and medical comorbidity in the Systematic Treatment Enhancement Program for Bipolar Disorder

(2011) P. V. Magalhães et al.   ACTA PSYCHIATRICA SCANDINAVICA

Adjunctive nutraceuticals with standard pharmacotherapies in bipolar disorder: a systematic review of clinical trials

(2011) Jerome Sarris et al.   BIPOLAR DISORDERS

The activation of monocyte and T cell networks in patients with bipolar disorder

(2011) Roosmarijn C. Drexhage et al.   BRAIN BEHAVIOR AND IMMUNITY

An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses

(2011) A. Carlo Altamura et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Cytokines and brain excitability

(2011) Michael A. Galic et al.   FRONTIERS IN NEUROENDOCRINOLOGY

Effects of lithium on lipopolysaccharide-induced inflammation in rat primary glia cells

(2011) Sigalit Nahman et al.   Innate Immunity

Inflammatory markers and their relationships with leptin and insulin from acute mania to full remission in bipolar disorder

(2011) Shang-Ying Tsai et al.   JOURNAL OF AFFECTIVE DISORDERS

Meta-Analysis of the Effects of Eicosapentaenoic Acid (EPA) in Clinical Trials in Depression

(2011) M. Elizabeth Sublette et al.   JOURNAL OF CLINICAL PSYCHIATRY

Systemic toxicity in early-stage mood disorders

(2011) Pedro V.S. Magalhães et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia

(2011) Sigrun Hope et al.   JOURNAL OF PSYCHIATRIC RESEARCH

The ageing systemic milieu negatively regulates neurogenesis and cognitive function

(2011) Saul A. Villeda et al.   NATURE

Specifying the Neuropsychology of Affective Disorders: Clinical, Demographic and Neurobiological Factors

(2011) Thomas Beblo et al.   NEUROPSYCHOLOGY REVIEW

Mediators of allostasis and systemic toxicity in bipolar disorder

(2011) Iria Grande et al.   PHYSIOLOGY & BEHAVIOR

Systemic illness moderates the impact of N-acetyl cysteine in bipolar disorder

(2011) P.V. Magalhães et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Synaptic Pruning by Microglia Is Necessary for Normal Brain Development

(2011) R. C. Paolicelli et al.   SCIENCE

Features of Microglia and Neuroinflammation Relevant to Environmental Exposure and Neurotoxicity

(2011) Andrew D. Kraft et al.   International Journal of Environmental Research and Public Health

Tumor necrosis factor-alpha mediated signaling in neuronal homeostasis and dysfunction

(2010) Keigan M. Park et al.   CELLULAR SIGNALLING

Understanding the role of inflammatory-related pathways in the pathophysiology and treatment of psychiatric disorders: evidence from human peripheral studies and CNS studies

(2010) Brian Dean   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Peripheral biomarkers and illness activity in bipolar disorder

(2010) Flávio Kapczinski et al.   JOURNAL OF PSYCHIATRIC RESEARCH

A systemic toxicity index developed to assess peripheral changes in mood episodes

(2010) F Kapczinski et al.   MOLECULAR PSYCHIATRY

Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors

(2010) M. Berk et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Evolution of neuropsychological dysfunction during the course of schizophrenia and bipolar disorder

(2010) K. E. Lewandowski et al.   PSYCHOLOGICAL MEDICINE

Cytokines and the immunomodulatory function of the vagus nerve

(2009) G.R. Johnston et al.   BRITISH JOURNAL OF ANAESTHESIA

Inflammation and the Phenomenology, Pathophysiology, Comorbidity, and Treatment of Bipolar Disorder

(2009) Benjamin I. Goldstein et al.   JOURNAL OF CLINICAL PSYCHIATRY

Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients

(2009) J S Rao et al.   MOLECULAR PSYCHIATRY

The potential use of biomarkers as an adjunctive tool for staging bipolar disorder

(2009) Flávio Kapczinski et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study

(2008) Fabiano G. Nery et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL